Hsbc Holdings PLC raised its holdings in shares of Xylem Inc. (NYSE:XYL – Free Report) by 2.1% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,000,691 shares of the industrial products company’s stock after acquiring an additional 41,825 shares during the period. Hsbc Holdings PLC owned approximately 0.82% of Xylem worth $272,622,000 as of its most recent SEC filing.
A number of other institutional investors also recently added to or reduced their stakes in the business. Callahan Advisors LLC bought a new stake in shares of Xylem in the 4th quarter worth $1,721,000. Northwestern Mutual Wealth Management Co. boosted its stake in Xylem by 2,309.7% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 431,824 shares of the industrial products company’s stock valued at $54,314,000 after buying an additional 413,904 shares in the last quarter. Abacus Wealth Partners LLC acquired a new position in Xylem during the fourth quarter worth about $1,663,000. Boston Common Asset Management LLC grew its holdings in Xylem by 15.3% during the fourth quarter. Boston Common Asset Management LLC now owns 143,740 shares of the industrial products company’s stock worth $19,575,000 after acquiring an additional 19,073 shares during the period. Finally, Norges Bank bought a new stake in Xylem in the fourth quarter worth about $361,012,000. Institutional investors and hedge funds own 87.96% of the company’s stock.
Xylem Trading Up 0.8%
Xylem stock opened at $118.22 on Friday. Xylem Inc. has a 52 week low of $105.29 and a 52 week high of $154.27. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.10 and a current ratio of 1.46. The firm has a market capitalization of $28.10 billion, a price-to-earnings ratio of 29.41, a P/E/G ratio of 1.67 and a beta of 1.03. The company has a 50 day moving average price of $112.72 and a 200 day moving average price of $124.71.
Xylem Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Thursday, June 25th. Shareholders of record on Thursday, May 28th were given a dividend of $0.43 per share. The ex-dividend date was Thursday, May 28th. This represents a $1.72 dividend on an annualized basis and a yield of 1.5%. Xylem’s dividend payout ratio (DPR) is presently 42.79%.
Insider Activity
In other Xylem news, Director Jerome A. Peribere bought 1,210 shares of the company’s stock in a transaction dated Monday, May 4th. The shares were bought at an average price of $116.61 per share, for a total transaction of $141,098.10. Following the acquisition, the director directly owned 27,209 shares of the company’s stock, valued at approximately $3,172,841.49. This trade represents a 4.65% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CAO Geri-Michelle Mcshane sold 4,269 shares of the stock in a transaction that occurred on Thursday, May 7th. The stock was sold at an average price of $117.46, for a total transaction of $501,436.74. Following the completion of the sale, the chief accounting officer directly owned 3,605 shares of the company’s stock, valued at $423,443.30. This trade represents a 54.22% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders own 0.32% of the company’s stock.
Analysts Set New Price Targets
XYL has been the subject of several research reports. Weiss Ratings lowered shares of Xylem from a “hold (c+)” rating to a “hold (c)” rating in a research report on Friday, May 8th. Barclays cut their target price on shares of Xylem from $156.00 to $154.00 and set an “overweight” rating for the company in a research note on Wednesday, April 29th. Jefferies Financial Group upgraded shares of Xylem from a “hold” rating to a “buy” rating and raised their target price for the stock from $130.00 to $140.00 in a report on Thursday, June 25th. UBS Group upped their price target on Xylem from $132.00 to $133.00 and gave the company a “neutral” rating in a report on Wednesday, April 29th. Finally, Oppenheimer cut their price objective on Xylem from $160.00 to $158.00 and set an “outperform” rating for the company in a research report on Wednesday, April 29th. Eight research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $153.54.
Check Out Our Latest Research Report on Xylem
About Xylem
Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.
The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.
Recommended Stories
- Five stocks we like better than Xylem
- Shorting the Grid: Bloom Energy’s $25B AI Power Play
- SanDisk’s Volatility May Be Telling Bulls What They Want to Hear
- Meta’s AI Compute Push Could Turn Its Massive CapEx Bill Into a Competitive Weapon
- 3 Dividend ETFs Built for Stability in a Volatile Market
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL – Free Report).
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.
